Pharming (PHAR) Notes Payables (2019 - 2021)

Pharming (PHAR) posted Notes Payables of $54000.0 for Q3 2021, down 23.94% on a QoQ basis from $71000.0 in Q2 2021.

Pharming (PHAR) Notes Payables (2019 - 2021) Analysis & Trends

Pharming's Notes Payables history runs 3 years deep, the most recent figure standing at $54000.0 for Q3 2021.

Quarterly Notes Payables changed N/A year-over-year to $54000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $54000.0 (changed N/A YoY) and the FY2020 annual result came in at $181000.0, down 39.87% from the prior year.
Notes Payables was $54000.0 for Q3 2021 at Pharming, down from $71000.0 in the prior quarter.
Across five years, Notes Payables topped out at $296645.9 in Q4 2019 and bottomed at $54000.0 in Q3 2021.
A 3-year average of $136182.5 and a median of $84000.0 in 2021 frame the typical range for Notes Payables.
Peak annual rise in Notes Payables reached 40.92% in 2020, while the deepest fall reached 40.92% in 2020.
Pharming's Notes Payables stood at $296645.9 in 2019, then slumped by 40.92% to $175266.6 in 2020, then tumbled by 69.19% to $54000.0 in 2021.
Business Quant data shows PHAR's Notes Payables at $54000.0 in Q3 2021, $71000.0 in Q2 2021, and $84000.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Pharming	9.02 Bn	8.96 Bn	65.80 Mn

Download Data